Editorial: Gut microbiota as a therapeutic target in neuropsychiatric disorders: current status and future directions

Hualin Cai; Xia Chen; Aurelijus Burokas; Rafael Maldonado

doi:10.3389/fnins.2023.1198291

Editorial: Gut microbiota as a therapeutic target in neuropsychiatric disorders: current status and future directions

Front Neurosci. 2023 May 23:17:1198291. doi: 10.3389/fnins.2023.1198291. eCollection 2023.

Authors

Hualin Cai^{1

2

3}, Xia Chen⁴, Aurelijus Burokas⁵, Rafael Maldonado^{6

7}

Affiliations

¹ Department of Pharmacy, Second Xiangya Hospital of Central South University, Changsha, China.
² The Institute of Clinical Pharmacy, Central South University, Changsha, China.
³ International Research Center for Precision Medicine, Transformative Technology and Software Services, Hunan, China.
⁴ Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
⁵ Department of Biological Models, Institute of Biochemistry, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
⁶ Laboratory of Neuropharmacology-Neurophar, Department of Medicine and Life Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
⁷ Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

No abstract available

Keywords: gut microbiota; neuropsychiatry disorder; prebiotics; probiotics; psychotropic drugs.

Publication types

Editorial

Grants and funding

This work was supported in part by the grants from Hunan Provincial Natural Science Foundation of China (2021JJ30922), Hunan Provincial Health Commission Research Project (202113010595), Talent Project established by Chinese Pharmaceutical Association Hospital Pharmacy Department (No. CPA-Z05-ZC-2021-003), and New Clinical Medical Technology Project of the Second Xiangya Hospital of Central South University ([2021]94).